✨ Free AI Report
ISTA Pharmaceuticals: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research ISTA Pharmaceuticals
Company Research

ISTA Pharmaceuticals: Business Overview, Financials & Competitive Analysis

ISTA Pharmaceuticals was a specialty pharmaceutical company headquartered in Irvine, California that specialized in ophthalmic drugs for inflammation, ocular pain, glaucoma, allergy, and dry eye. The company was acqui...

Cyborg Score recalibrated: November 16, 2026
AI-Generated Research
30+ Page Report

Get the Latest ISTA Pharmaceuticals Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for ISTA Pharmaceuticals

AskCyborg analysts argue the bull and bear cases for ISTA Pharmaceuticals across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
ISTA Pharmaceuticals OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

ISTA Pharmaceuticals Overview

Pro stress-test →

ISTA Pharmaceuticals was a specialty pharmaceutical company headquartered in Irvine, California that specialized in ophthalmic drugs for inflammation, ocular pain, glaucoma, allergy, and dry eye. The company was acquired by Bausch & Lomb in June 2012 for $500 million and subsequently became part of Valeant Pharmaceuticals in July 2013, ending independent operations.

Strategic Profile

Pro stress-test →

ISTA positioned itself as a focused ophthalmic specialist with FDA-approved products (BROMDAY, BEPREVE, ISTALOL, VITRASE) and a pipeline targeting ocular inflammation, pain, and glaucoma. The acquisition by Bausch & Lomb was designed to enhance the larger company's pharmaceutical portfolio and expand its ophthalmic pipeline, complementing B+L's existing prescription and OTC eye care products.

Competitive Landscape

Pro stress-test →

Prior to acquisition, ISTA competed against major pharmaceutical and specialty companies including Allergan, Alcon, Amphastar, Johnson & Johnson, Novartis, Pfizer, and Inspire Pharmaceuticals in ophthalmic markets. The company faced significant competition from generic drug manufacturers, particularly in glaucoma and anti-inflammatory categories.

Industry Context

ISTA Pharmaceuticals operates in Pharmaceuticals.

Key facts

Founded: 1992 · Headquarters: Irvine, California

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on ISTA Pharmaceuticals.

  • Prior to acquisition, ISTA was the fourth-largest branded prescription eye care business in the US
  • Product portfolio included four key marketed drugs addressing postoperative inflammation, allergic conjunctivitis, glaucoma, and vitreous hemorrhage
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • June 2012Acquisition by Bausch & Lomb completed for $500 million
  • May 2013ISTA pleaded guilty to federal felony charges related to Xibrom misbranding and illegal remuneration; agreed to $33.5 million settlement
  • +1 moreTrack every material event for ISTA Pharmaceuticals as it happens. Explore monitoring →
Get alerted when ISTA Pharmaceuticals has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Compare ISTA Pharmaceuticals with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

ISTA Pharmaceuticals operates in Pharmaceuticals. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceuticals research →
NEW · MCP server

Ask your AI assistant about ISTA Pharmaceuticals

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare ISTA Pharmaceuticals and its top competitor on Cyborg Score”
“What did ISTA Pharmaceuticals do this quarter?”
“Is ISTA Pharmaceuticals a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does ISTA Pharmaceuticals do?+
ISTA Pharmaceuticals was a specialty pharmaceutical company headquartered in Irvine, California that specialized in ophthalmic drugs for inflammation, ocular pain, glaucoma, allergy, and dry eye. The company was acqui...
What is ISTA Pharmaceuticals's Cyborg Score?+
The Cyborg Score is a 1-10 rating from the AskCyborg multi-agent analyst-debate framework. Recalibrated weekly across business, financials, leadership, competitive position, technology, marketing, and ESG dimensions.
Who are ISTA Pharmaceuticals's main competitors?+
Named competitors include Allergan Ophthalmology Products, Alcon Eye Care Products, Inspire Pharma Ophthalmology. The full competitive landscape is in the AskCyborg report.
How can I get the full ISTA Pharmaceuticals research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the ISTA Pharmaceuticals research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.